Efficacy and Safety of Mildronate for Acute Ischemic Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.
Also called NCT01800357
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 240 participants
- Sponsor
- Registry
-
NCT01800357
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01800357. Randomized; quadruple masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2014-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Mildronate for Acute Ischemic Stroke
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- infusion of mildronate
- Intervention (Drug)
- placebo
- Intervention (Drug)
- aspirin
- Lead sponsor
- Xijing Hospital
Record details
- Record id
cardio:ct-nct01800357- Content hash
4e1846d5165bc77fea129141f3e41fb42b09a12d389d3a9ce105c486fa19c510